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The use of spliced vein bypasses for 
infrainguinal arterial reconstruction 
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Dhiraj M. Shah, MD, and Robert P. Leather, MD, Albany, N.Y. 
Purpose: The use of autogenous vein, whether in situ or excised, for medal  bypass 
procedures i well accepted. However, this usually requires the presence of a length of 
good-quality vein of adequate diameter. In patients lacking sufficient length of vein, two 
or more pieces of vein may be spliced together to complete the reconstruction. The effect 
of vein splicing on vein bypass patency is not well studied. 
Methods: Over a 14-year period, 1956 lower extremity revascularizations were performed 
with a single autogenous vein, 1806 in situ and 150 excised veins. During the same time, 
184 bypasses required splicing vein segments ogether, of which 111 were in situ bypass 
procedures, which required splicing of one or more pieces of excised vein to complete the 
reconstruction (partial in situ bypass). Seventy-three bypasses were completed with 
multiple pieces of spliced excised vein. The source for the excised, spliced vein segments 
was the distal ipsilateral greater saphenous vein (GSV) in 40%, accessory ipsilateral GSV 
in 8%, contralateral GSV in 13%, lesser saphenous vein in 28%, and arm vein in 11%. 
Results: The 1- and 4-year primary patency rates for the entire spliced vein group were 72% 
and 45%, with secondary patency rates of 79% and 61%. The 1- and 4-year secondary 
patency rates of partial in situ bypasses were 80% and 70%, compared with 91% and 83% 
for in situ bypasses completed without a spliced segment (p < 0.0001). The 1- and 4-year 
secondary patency rates were 78% and 67% in the spliced excised vein group and 85% and 
75% in the single excised vein group (p = not significant). The 4-year limb salvage rates 
were as follows: in situ (96%), partial in situ (85%), single excised vein (95%), and spliced 
excised vein (90%). 
Conclusions: We conclude that the use of excised vein segments o complete partial in situ 
bypasses may be associated with a decrement ofbypass patency. Use of spliced excised vein 
segments of good quality for arterial bypass can produce acceptable patency rates. Such 
spliced autogenous conduits are clearly preferable to prosthetic bypasses for infragenic- 
ulate arterial reconstructions. Meticulous technique is a prerequisite for the successful 
performance of vein-to-vein anastomoses. (J VASC SURG 1995;21:403-12.) 
There is little question that autogenous greater 
saphenous vein is the most ideal conduit for infrain- 
guinal arterial bypass. The proven superiority of 
autogenous saphenous vein over prosthetic onduits 
has led some surgeons to adopt a policy of use of 
autogenous veins of any kind in preference to 
prosthetic conduits. 1,2 In those patients lacking 
complete suitable ipsilateral greater saphenous vein, 
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such a policy requires the use of distal inflow sources 
and arm, lesser saphenous, or contralateral orresidual 
greater saphenous veins. 36 The application of such 
alternative vein sources is often limited by their 
length. Venovenostomy is one method of creating a
longer conduit when needed. 2,7,8 However, relatively 
few of these spliced bypasses have been subjected to 
scrutiny in the literature. The object of this report is 
to examine the performance of spliced vein bypasses 
to determine whether they function as well as 
conventional saphenous vein bypass or at least better 
than prosthetic onduits. 
MATERIAL AND METHODS 
Over a 14-year period from 1979 to 1993, 2140 
infrainguinal arterial bypasses were performed en- 
tirely with autogenous vein. Of this group, 1956 
were completed with a single length of vein with 
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Table I. Autogenous pliced vein 
bypass - deficiency of ipsilateral greater 
saphenous vein 
No. % 
Absent ipsilateral GSV 63 (34%) 
Previous vascular surgery 43 
Previous CABG 18 
Varicose vein excision 2 
Inadequate ipsilateral GSV 100 (54%) 
Small size ( <2.5 ram) 37 
Thrombosis 22 
Sclerosis 10 
Recanalized 7 
Varicosities 3 
Calcification 1 
Intraoperative njury 20 
Revision of distal anastomosis (ISB) 21 (12%) 
GSV, Greater saphenous vein; CABG, coronary artery bypass 
grafting; ISB, in situ bypass. 
either an in situ (1806) or excised vein (150) 
technique. One hundred eighty-four bypasses were 
completed with at least wo segments of autogenous 
vein requiring venovenostomy. This latter group is 
the principal subject of this report. The typical patient 
in this series was a diabetic (54%) man (64%) with 
a history of coronary artery disease (63%) and 
smoking (70%). Ninety-five percent of these by- 
passes were performed for limb salvage. Bypasses 
performed for trauma were excluded from this 
analysis. Average follow-up time was 14.3 months 
(range I to 126 months). Follow-up was complete in 
95% of patients. 
The methods of performing distal arterial bypass 
have been extensively documented. 9,1° The in situ 
technique was used preferentially. Excised veins were 
harvested and distended with heparinized blood or a 
mixture of heparin/dextran 40/papaverine. Veins 
without significant aper were reversed (95 of 151 
excised single bypasses); veins with a marked taper 
were anastomosed in a nonreversed configuration, 
and their valves were incised with a modified Mills 
valvulotome (American V. Mueller, Chicago, Ill.) 
(56 of 151). The remaining multiple segments were 
all reversed. 
Venovenostomy was performed whenever the 
length of conduit available in a single length of vein 
was insufficient o complete the bypass procedure. 
Venovenostomy was usually performed end to end 
with 8.0 polypropylene suture. Vein segments with 
large differences in diameter were sometimes anas- 
tomosed end to side (smaller onto larger). Conduits 
were constructed with an effort to place the larger 
conduits proximally and the smallest most distally. 
Vein wall ischemia in all cases was minimized by 
perfusion with arterial blood after completion of the 
proximal anastomosis, n New arterial blood was 
allowed to perfuse the bypass at least every 15 
minutes. More distal segments were harvested only 
after the proximal segment was perfused. 
Of the 184 spliced vein bypass procedures re- 
ported in this series, 111 bypasses consisted of a 
segment prepared with an in situ technique anasto- 
mosed to a segment or segments of excised vein 
(partial in situ bypass). Only seven of these were 
performed for claudication. The remaining 73 spliced 
vein bypasses were constructed entirely from excised 
vein segments. All of these bypasses were performed 
for critical ischemia. These patients typically lacked 
enough ipsilateral greater saphenous vein to com- 
plete the proposed reconstruction. The reasons for 
this deficiency are noted in Table I. Fifty-five (75%) 
of the excised spliced vein group contrasted with 
eight (7%) of the partial in situ bypass group had 
absent ipsilateral greater saphenous vein as a result of 
previous vascular surgery, coronary artery bypass 
grafting, or varicose vein excision. Ipsilateral greater 
saphenous vein was present but too small, too short, 
or otherwise inadequate to complete the reconstruc- 
tion in 18 (25%) of the spliced excised vein bypasses 
and in 82 (74%) of the partial in situ bypasses. In 
addition 21 in situ bypasses required further conduit 
length for revision of the distal anastomosis at the 
time of the original procedure. 
The bypasses performed are noted in Table II, 
delineating the sites of the proximal and distal 
anastomoses. Most of the revascularizations origi- 
nated from the common femoral artery (36%), deep 
femoral artery (32%), or superficial femoral artery 
(25.5%). One hundred fifty-five bypasses (84%) 
terminated in a tibial or pedal artery. This distribu- 
tion of distal anastomosis similar to our overall 
series. 
The 184 spliced vein bypasses were composed of 
293 excised vein segments, the sources of which are 
listed in Table 111. Forty-eight percent of the 
segments were a portion of the ipsilateral greater 
saphenous vein, usually the distal aspect of the main 
trunk or an accessory branch. Lesser saphenous vein 
(ipsilateral or contralateral) was used in 28%. One 
hundred fifty-one bypasses were constructed from 
two vein segments, 30 from three segments, and 
three from four vein segments. 
Bypass patency was assessed with intraopera- 
tive Doppler ultrasonography and angiography. 
Follow-up involved physical examination, pulse vol- 
ume recordings, segmental pressures, and duplex 
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Table II. Autogenous spliced vein bypass - sites of proximal and distal anastomosis 
DISTAL ANAST CFA DFA SFA POP TIB Total (%) 
AK POP 3 2 0 0 0 5 3% 
BK POP 7 10 7 0 0 24 13% 
TIB 51 43 34 3 0 131 71% 
PEDAL 6 3 6 8 1 24 13% 
Total 67 58 47 11 1 184 100% 
(%) 36% 32% 25.5% 6% .5% 
CFA, Common femoral artery; DFA, deep femoral artery; SFA, superficial femoral artery; POP, popliteal artery; T/B, tibial arteries; AK, 
above-knee; BK, below-knee. 
ultrasound imaging. These examinations were per- 
formed within 30 days, then every 3 months for 6 to 
12 months and every 6 months thereafter. Duplex 
ultrasound imaging of the entire length of the bypass 
was performed. A stenosis was suggested by a 
segmental peak systolic velocity twice that of the 
proximal bypass flow, without change in bypass 
diameter. Hyperemic flow changes were also evalu- 
ated. Bypasses that occluded or became stenotic were 
then examined with arteriography. 
Primary patency indicates continued patency of 
the conduit without further manipulation. Bypasses 
subsequently subjected to fistula ligation, patch 
angioplasty, segmental replacement, or (rarely) an- 
gioplasty with continued patency are included in the 
secondary patency group. Limb salvage is defined as 
maintenance of limb function without below- or 
above-knee amputation. Patency and limb salvage 
rates have been calculated by use of life-table analysis. 
Comparisons of life-table stimates were performed 
by the Mantel-Cox log rank test of significance with 
the Biomedical Data Processing statistical software 
package (BMDP Statistical Software, Inc., Los 
Angeles, Calif,). Statistical significance was accepted 
asp < 0.05. The conventions used are in accordance 
with the Ad Hoc Committee on Reporting Stan- 
dards, The Society for Vascular Surgery/North 
American Chapter, International Society for Cardio- 
vascular Surgery. 12 
RESULTS 
The 30-day perioperative mortality rate was 
4.4%, and the nonfatal complication rate was 9.5%. 
The primary and secondary patency rates for the 
entire spliced vein group are presented in Table IV 
and Fig. 1. The 1- and 4-year primary patency rates 
were 72% and 45%, whereas the secondary patency 
rates were 79% and 61%. The effect on secondary 
patency of the number of spliced segments in series 
is depicted in Fig. 2. An increase in the number of 
venovenostomies performed id not cause a decre- 
Table III. Autogenous spliced vein 
bypass - source of excised vein segments 
No. % 
GSV - ipsilateral i 18 40 
Accessory GSV - ipsilateral 22 8 
GSV - contralateral 37 13 
LSV - ipsilatcral 65 22 
LSV - contralateral 19 6 
Cephalic/brachial 3 3 11 
GSV, Greater saphenous vein; LSV, lesser saphenous vein. 
ment in patency rates (two segments 71%, three and 
four segments 84% at 3 years). The limb salvage for 
the spliced vein group is presented in Table V and 
Fig. 3. The cumulative 5-year limb salvage rate was 
84%, with a total of nine above-knee and six 
below-knee amputations. 
The primary and secondary patcncy rates of the 
partial in situ group only are presented in Table VI. 
The 4-year primary patency rate was 48%, contrasted 
with a 70% secondary patcncy rate, indicating that 
multiple revisions were performed. The primary and 
secondary patency rates of the in sire bypass group 
are significantly different than those of the partial in 
situ group. Complete in situ bypasses have a 4-year 
primary patency rate of 75%, and a secondary 
patency rate of 83%. The 30-day primary patency 
rate was 86% in the parnal in situ group and 95% in 
the complete in situ bypass group. 
The primary and secondary patency rates of the 
spliced excised vein bypass group is presented in 
Table VII. The primary patency rate at 2 years was 
53%, with the secondary patency rate being 67%. 
Patency rates beyond 2 years should be viewed for 
trends alone because of the sample size. This group is 
compared with the performance of all bypasses 
completed with a single segment of excised vein at 
our institution. The primary and secondary patency 
rates in the single excised vein group at 2 years were 
79% and 81% and at 4 years were 72% and 75%. The 
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Table IV, A. Primary patency - autogenous spliced vein 
Interval (mo  Bypasses at r isk  Revis ions Withdrawn Interval patency Cumulative patency SE (%) 
0-1 184 25 35 0.850 0.850 2.4 
2-12 124 15 58 0.842 0.716 3.4 
13-24 51 4 25 0.896 0.642 5.4 
25-36 22 0 9 1.000 0.642 8.2 
37-48 13 3 6 0.700 0.449 9.2 
Table IV, B. Secondary patency-  autogenous spliced vein 
Interval (mo O Bypasses at r isk  Occlusions Withdrawn Interval patency Cumulative patency SE (%) 
0-1 184 20 36 0.880 0.880 2.2 
2-12 128 10 61 0.897 0.789 3.2 
13-24 57 3 28 0.930 0.734 5.0 
25-36 26 0 11 1.000 0.734 7.4 
37-48 15 2 6 0.833 0.611 9.8 
Table V. Limb salvage - autogenous spliced vein 
Interval (mos) Limbs at r isk Amputations Withdrawn Interval patency Cumulative patency SE (%) 
0-1 184 12 42 0.926 0.926 1.9 
2-12 130 2 67 0.979 0.907 2.4 
13-24 61 0 31 1.000 0.907 3.5 
25-36 30 0 I2 1.000 0.907 5.0 
37-48 18 1 7 0.931 0.844 7.8 
secondary patency rates of spliced excised and single 
excised vein bypasses were not statistically significant 
(2 = 0.10) .  
The 3-year limb salvage rate was 90% in the 
spliced excised group, 95% in the single excised 
group, 91% in the partial in situ group, and 96% in 
the complete insitu group. Statistical significance was 
reached when comparing the in sire and partial in situ 
groups (2 = 0.0001), but not the single excised and 
spliced excised groups. 
Fifty-six percent of the spliced excised vein 
bypasses and 26% of the partial in sire bypasses were 
performed in limbs that had previous bypass proce- 
dures (secondary econstructions). The number and 
percentage of primary and secondary revasculariza- 
tions in each group are listed in Table VIII. The 
1-year secondary patency rate was 84% in primary 
reconstructions forboth groups and 73% and 69% in 
the secondary econstructions for the spliced excised 
and partial in situ bypass groups respectively. This 
was not, however, statistically significant. 
Of the 20 limbs with an occluded partial in situ 
bypass, seven underwent a follow-up vascular proce- 
dure (three vein, three polytetrafluoroethylene 
[PTFE], one composite sequential). Seven bypasses 
were revised for progression of distal disease 
(n = 4), for bypass stenoses (n = 2), and for 
resection of an aneurysmal segment (n = 1). Five 
limbs survived without additional surgery, and 
eight underwent amputation. A total of nine limbs 
(8%) were amputated, including one hemo- 
dynamic failure. One stenosis was in the vein 
segment of poor quality and one at the venove- 
nostomy. 
In the spliced, excised vein bypass group, there 
were 15 bypass occlusions. Seven of these limbs 
required a new bypass procedure for persistent or 
recurrent symptoms (four vein, three PTFE). The 
conduit for two of the new vein bypasses was spliced 
vein, and the remaining two were single excised 
contralateral greater saphenous vein. An additional 
five bypasses required revisions, including interpo- 
sition or patch of vein graft stenoses (n = 3), distal 
bypass extension (n = 3), and inflow revision 
(n = 1). Two stenoses were related to vein dete- 
rioration, with one at the venovenostomy. Three of 
the limbs with an occluded excised spliced vein 
bypass urvived intact without intervention, and five 
underwent a knee-level amputation. One limb re- 
quired amputation in spite of a patent bypass 
(hemodynamic failure) for a total amputation rate 
of 8.2%. 
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Fig. 1. Cumulative primary and secondary patency of all spliced vein bypasses (partial in situ 
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Fig. 2. Cumulative secondary patency of all spliced vein bypasses, comparing the number of 
vein segments in each bypass. 
DISCUSSION 
The bypass options available to the vascular 
surgeon for the management of infrainguinal occlu- 
sive disease center around the use of the ipsilateral 
greater saphenous vein. Whether used as an in situ 
conduit or as an excised (usually reversed) vein 
bypass, primary patency rates in the 60% to 70% 
range at 5 years may be achieved for long bypasses to 
the tibia] and crural levels. 8,13 Careful graft surveil- 
lance and judicious revisions may increase secondary 
patency rates to just over 80% at 5 years. 8,1~,14 
Unfortunately, the ipsilateral greater saphenous 
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Table VI,  A. Primary patency - partial in situ bypasses 
Interval (mos) Bypasses at r i sk  Revis ions Withdrawn Interval patency Cumulative patency SE (%) 
0-1 111 14 26 0.857 0.857 3.4 
2-12 71 9 29 0.841 0.721 4.5 
13-24 33 1 13 0.962 0.694 6.6 
25-36 19 0 7 1.000 0.694 8.8 
37-48 12 3 5 0.684 0.475 9.9 
Table VI,  B. Secondary patency - partial in situ bypasses 
Interval (mos) Bypasses at r i sk  Occlusions Withdrawn Interval patency Cumulative patency SE (%) 
0-1 111 12 28 0.876 0.876 2.9 
2-12 71 5 30 0.911 0.798 4.2 
13-24 36 1 14 0.966 0.771 6.1 
25-36 21 0 8 1.000 0.771 8.1 
vein may be limited or otherwise unusable in a 
significant number of  patients requiring bypass. The 
percentage of these cases in our series is approxi- 
mately 15% to 20%, but is as high as 45% in some 
series. 8 In some of these cases, the use of the 
contralateral greater saphenous vein is appropriate, 
except in those patients with severe occlusive disease 
in the potential donor limb. Approximately 15 % of 
such patients will eventually require bypass proce- 
dures in both limbs. ~3 
Management of the remaining cases involves the 
use of alternative inflow and outflow options, as well 
as alternative vein sources uch as arm, lesser saphe- 
nous, and residual greater saphenous veins. Because 
these alternative veins are relatively short, their use 
more often demands the use of  distal inflow sources, 
venovenostomy (splicing), or sequential techniques 
for successful limb salvage. The purpose of this study 
was to examine the results of spliced vein bypasses to 
determine how these bypasses fit into the panoply of  
options available to the vascular surgeon. 
The 4- and S-year primary patency rates of the 
entire spliced vein group were 44.9%; surveillance 
and revisions raised the secondary patency rates to 
61%. The number of venovenostomy anastomoses 
performed in series did not appear to affect the 
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Table VII, A. Primary patency - spliced excised vein 
Interval (mos) Bypasses at r isk Revis ions Withdrawn Interval patency Cumulative patency SE (%) 
0-1 73 11 9 0.839 0.839 3,9 
2-12 53 6 29 0.844 0.708 5,2 
13-24 18 3 12 0.750 0.531 8.6 
Table VII, B. Secondary patency - spliced excised vein 
Interval (mos) Bypasses at r isk Occlusions Withdrawn Interval patency Cumulative patency SE (%) 
0-1 73 8 8 0.884 0.884 3.5 
2-12 57 5 31 0.880 0.778 4.9 
13-24 21 2 14 0.857 0.667 8.4 
patency. The limb salvage rate was gratifyingly high, 
84.4%, at 4 years. Harris et al. 7 reported on spliced 
vein bypasses and demonstrated a I-year patency rate 
of 72%; our results were nearly identical (71.6%). 
Use of venovenostomy has also been mentioned as a 
part of larger series, notably that of Taylor et al. 8 (70 
of 564 limbs that underwent operation) and Donald- 
son et al.2 (30 of 537 limbs). The 2-year secondary 
patency rate was 83% in the former series and 62% 
in the latter series; ours was 73.4%. This series of 184 
cases is the largest and most detailed report available 
for spliced vein bypasses, with follow-up of 4 to 5 
years. 
How then should these data be regarded in view 
of the other options available? In patients with 
limited autogenous vein, use of a more distal inflow 
site will demand less bypass length. The undiseased 
superficial femoral and deep femoral arteries may be 
used with impunity with no decrement in patency 
rates, a,13 The popliteal artery, when undiseased, may 
be used as an inflow source for distal bypass 
procedures; Wengerter et al. a reported a 75% 2-year 
primary patency rate for these reconstructions, a 
Finally, tibial arteries may be used as distal inflow 
sources in rare cases, is 
Because the results with popliteal-to-distal by- 
passes appear to be comparable or superior to the 
results of spliced vein bypasses, and because it is 
technically easier, use of nonstenotic distal inflow 
sources is to be preferred to venovenostomy when 
anatomically possible, 
Composite sequential bypass has been reported to 
have a 48% 3-year primary patency rate and may 
therefore have a slightly inferior performance com- 
pared with venovenostomy.16 Autogenous femoral- 
-to-isolated popliteal artery bypasses have good 
patency rates (70% at 2 years) but significant rates of 
Table VIII. Primary versus 
secondary reconstructions 
Primary No. Secondary No.
(%) (%) 
Spliced excised 32 (44) 41 (56) 
Excised single 101 (67) 49 (33) 
Partial in situ 82 (74) 29 (26) 
Primary, First reconstructive procedure; Secondary, previous re- 
constructive procedure(s) were performed. 
hemodynamic failure and are probably best reserved 
for cases requiring only a small increment in foot 
perfusion (e.g. rest pain)) Because of the good 
patency rates and excellent limb salvage rates with 
spliced vein bypasses, we prefer this option over 
composite sequential nd isolated popliteal bypasses. 
The use of PTFE for infrainguinal bypass has 
generally lost favor. Although some reports docu- 
ment a 51% 5-year primary patency rate for PTFE 
femoropopliteal bypasses for limb salvage, results by 
others have been less favorable.It,1 Use of spliced vein 
bypass is probably superior to PTFE-below-knee 
popliteal artery bypass and clearly superior for bypass 
to infrapopliteal rteries. In the few patients under- 
going limb salvage with a patent continuous above- 
knee popliteal artery, use of PTFE or venovenostomy 
may be roughly comparable. 
Therefore we regard spliced vein as a useful 
option in many cases, and it is to be preferred for 
femorotibial bypass from the groin in patients lacking 
a sufficient single length of greater saphenous vein. It 
should be noted that vein splicing requires the 
surgeon to have an extensive knowledge of arm and 
leg vein anatomy. Use of arn% lesser saphenous, and 
residual greater saphenous vein has been reported 
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elsewhere; venovenostomy increases the uti l ity o f  
these alternative vein sources. 
We acknowledge Paul Feustel, PhD, for his assistance 
with the statistics, supported in part by N IH NS30303. 
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D ISCUSSION 
Dr. Michael Belkin (Boston, Mass.). This review of 
184 composite vein bypass grafts represents the largest 
series that I am aware of and sets a standard against which 
vascular surgeons can compare their results with spliced 
vein grafts. I took this opportunity to review our results 
with 66 composite vein graft procedures performed be- 
tween 1987 and 1993 and found that our 76% 3-year 
secondary patency rate is remarkably similar to the authors' 
report. It was most striking in our series, however, that 
29% of these composite bypasses required vein graft revi- 
sions to maintain patency. This stands in stark contrast to 
the 7% revision rate we have noted in our single-segment 
vein bypasses. Furthermore, the great majority of vein graft 
stenoses that we have identified in composite vein grafts 
have occurred at the site of the venovenostomy. What are 
the comparative revision rates for your composite vein 
grafts, as compared with your single segment bypass grafts? 
We believe that routine graft surveillance with duplex scan- 
ning is essential in maintaining patency of these composite 
grafts. Would you elaborate on your vein graft surveillance 
protocol? What are your thresholds for vein graft revision? 
Is your experience similar to ours, with the majority of 
stenotic lesions occurring at the site of the venovenostomy? 
lfso, can you shed any light on how to prevent this perplex- 
ing problem? How much do you inspect the veins at the site 
of the venovenostomy? Do you ever use interrupted su- 
tures? Do you ever incorporate vein branch points to en- 
large the heel of the venovenostomy suture line? 
How do you select your source of excised vein 
segments? It was somewhat surprising to me that 28% of 
the excised vein segments came from either ipsilateral or 
contralateral lesser saphenous vein, whereas only 13 % came 
from contralateral greater saphenous vein. It is our belief 
that the best available conduit should be used to complete 
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any given vascular econstruction. Generally, when pos- 
sible, we use a portion of the contralateral greater 
saphenous vein as a segment of a composite vein graft. 
When we are confronted with a patient who lacks greater 
saphenous vein, we will perform acomprehensive survey of 
the arm and lesser saphenous veins before operation with 
duplex scanning. On the basis of the results, we select he 
best available vein segments to complete our composite 
vein graft. What is your algorithm for selecting vein 
segments? Do you use duplex scanning for preoperative 
vein mapping? 
Dr. Benjamin B. Chang. With regard to our surveil- 
lance protocol, in general, we obtain images within the first 
30 days, then every 3 months for the first year and every 6 
months thereafter. However, in this group, depending on 
the quality of the vein, we may obtain images more 
frequently. In some patients, we know that we are using 
sclerotic or compromised veins, and we will obtain images 
of them as often as every month if necessary. This depends 
on the presence and the number of potential lesions we see 
at the time of surgery. In any case, we generally will 
perform angiography on any lesion that appears to be a 
50% or greater stenosis, and we generally repair these. 
Angiograms are usually necessary because, if there has been 
a change in vein diameter at the venovenostomy, you may 
see a change in the flow velocity that may not reflect an 
actual abnormality. In general our revision rate for in situ 
or reversed bypasses comprised of a single conduit is 
approximately 5%. Our revision rate for spliced conduits is 
higher, approximately 12%. The reasons for these revisions 
are generally either disease progression distally or the 
development of bypass tenoses not at a venovenostorny. 
Five of the bypass tenoses revised were in two patients in 
whom we had to use arm vein that was clearly sclerotic and 
damaged from previous intravenous insertion. In those 
patients, we performed scanning every month. One patient 
had two stenoses fixed in a single bypass and one had three. 
Of the venovenostomies, there were two venovenostomy 
stenoses that were revised. Obviously, some of the bypasses 
that went on to occlusion may have had venovenostomy 
problems that we do not know of. But of the stenoses only 
two venovenostomies were involved. There are other subtle 
points that we do not have enough time to go into in this 
forum. But we do emphasize the avoidance of any 
intraluminal instrumentation i  performing any vein-to- 
artery or vein-to-vein auastamosis. If you use a catheter to 
dilate the veins, we always debride the area in contact with 
the catheter. We don't use any dilators. We don't handle the 
inside of the vein when we are anastomosing it. From these 
data, and even more so from the in situ data, overall we 
think that avoiding long-term late stenoses i contingent on 
this. 
As we said we perform most of these anastomoses nd 
to end with a single 8.0 running prolene suture. Usually, if 
there is a marked ifference in vein diameter, we will do an 
end-to-side anastomosis. Only in anastomosing two very 
small veins will we go to spatulation. Frankly, if the veins 
are so small that you have to spatulate them, I think you are 
in trouble at the time of the primary procedure. We 
occasionally use branch points to increase the diameter of 
the smaller vein at the anastomosis, but this is not universal. 
I agree with your use of vein mapping before operation. 
Basically in these patients we have our laboratory map every 
limb that the patient has and make our choices from this. 
Embarking on these procedures without preoperative in 
mapping is foolish. As far as vein selection, we typically 
prefer to use a single conduit when possible. Therefore, if 
we can do a femoropopliteal or popliteal-tibial anastomosis 
with a single greater saphenous or lesser saphenous vein, we 
will prefer to do that, as long as the inflow to that site is 
adequate. However, in those patients requiring a longer 
bypass and splicing, we typically make the vein choice on 
the basis of a combination of vein quality, as well as the 
number of limbs needed. Most ofken we can complete a
bypass to the mid calf with a lesser saphenous vein and a 
small piece of residual greater saphenous vein from the 
ankle. Therefore we will try to stay in one limb. If more is 
needed, we try to stay in both lower extremities, if possible. 
If  those options are not available, then we will use arm vein. 
Arm vein in our experience is somewhat more tedious to 
work with than greater or lesser saphenous vein. There is 
a higher incidence of sclerotic sites from previous insertion 
of intravenous catheters, and therefore we do not favor the 
arm vein. But in any care I would like to stress that 
venovenostomies can be used with arm, lesser saphenous, 
or greater saphenous vein. So the point of the study isn't 
whether you use arm vein or leg vein, but simply that you 
can splice these together and they will work reasonably 
well. 
Dr. Thomas F. Panetta (Brooklyn, N.Y.). Would you 
comment on preexisting saphenous vein disease and the 
fact that spliced veins are not as good as a single vein 
segment? Our concern is that you are dealing with 
preexisting saphenous vein disease here. Do you have the 
data on the subsets of patients? Were some of these done 
for excised segments of preexisting disease, or were these 
cases done only because there were limited segments of vein 
available without disease? Are those two separate groups of 
patients? Do the spliced veins without preexisting disease 
have a better patency rate than the spliced veins with 
preexisting saphenous vein disease? With regard to iden- 
tifying this problem, what should we do to look for 
preexisting vein disease? Should we scope these veins? 
Should we take this to the limit where we do biopsies of the 
ends of the veins and look for an intimal medial thickness 
greater than 200 vein size come into play here? What's the 
smallest vein you'll use? Clearly the smaller diameter veins 
have lower patency rates. 
Dr. Chang. We live by two axioms regarding the 
quality of the greater saphenons vein. Bad vein, even if you 
treat it well, will perform poorly. Good vein, if you treat it 
well, will perform well. Of this series there are 100 limbs 
that we operated on for what we call inadequate greater 
saphenous vein, and 43 of these were inadequate because of 
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a combination of thrombosis, clerosis, recanalization, and 
so forth. These are the patients that we generally regard as 
having unsatisfactory conditions from the beginning. As far 
as detecting preexisting vein disease, typically we do not use 
endoscopy to detect his. Generally we rely on both the 
external appearance of the vein and the internal appearance 
of the vein when we cut it. If  there is any evidence of 
sclerosis or disease at the time that we harvest the vein, we 
may discard the vein if there is a nonsclerotic option 
available. If only sclerotic vein is available, depending on 
the need of the patient and the situation, we may use the 
vein and then perform completion angiography orDoppler 
examination. If there is what we regard as too high a rate 
for potential stenosis, we may yet discard that vein. In those 
patients in whom we know that we are using compromised 
vein of one sort or another, we will subject hem to much 
more frequent duplex scanning and try to recover those 
with secondary procedures. 
Dr. Panetta. Have you stratified the results between 
those 43 that had preexisting disease versus the other 57 
that didn't. Do you have differences in those patency rates? 
Dr. Chang. The differences in the patency rates that I 
can tell you about are linked in part to size, as well as 
inadequacy. If you have a nice lesser saphenous vein of 
good quality and good diameter, the results are generally 
better than if you started out with a small greater saphenous 
vein and anastomose another piece of small lesser saphe- 
nous vein or other compromised vein to it. So I agree vein 
quality is the major influence here. 
Dr. Wil l iam Carney. I want to discuss the addition of 
another alternative of which we are all at least vaguely 
aware. This is the use of the femoral vein. We continue to 
resort to this alternative occasionally when things are just 
not working out very well. It can provide about 18 inches 
if used from both thighs above the knee. The venous 
complications have been a problem, but they certainly are 
better than an amputation. I wonder if you have given this 
any consideration, or has the somewhat maligned role of 
this procedure deterred you completely from considering 
it? 
Dr. Chang. In general, because of the relatively large 
size of the superficial femoral vein, we typically do not use 
it for a conduit. However, we do use it for a patch material. 
In those patients in this group who later went on to a 
stenosis requiring a patch, we frequently used the superfi- 
cial femoral vein as the patch material. I do not have any 
experience with the use of the superficial femoral vein as a 
conduit, however. 
Dr. John J. Ricotta (Buffalo, N.Y.). When do you 
decide to take a small segment of the greater saphenous vein 
out because it's unsuitable and then do a venovenostomy? 
In other words, when do you still use the greater saphenous 
vein but do a venovenostomy because you see an area of 
sclerosis? How often did you do that? Are those patients 
included in this series? For you to decide that you are going 
to use a spliced vein, do you have the same limits of size that 
you do with an intact greater saphenous vein or are you 
more stringent about the quality of vein you use for 
splicing? 
Dr. Chang. If we are doing an in sire procedure and 
there is a I cm segment of stenosis in the mid thigh, we 
replace that. 
Dr. Ricotta. Those are not in this series. How often do 
you find that you have to do something in a very limited 
area? The venovenostomy is not a technical limitation both 
initially or with long-term results. But the caliber of that 
vein conduit was good, I assume. In these veins that were 
treated more recently and in the earlier group where you 
had only two segments spliced together, were your results 
not nearly as good? Is there something in that group other 
than just a number of conduits you put together? 
Dr. Chang. Because we do not believe the venovenos- 
tomy works, we will be more likely to take three pieces of 
good vein rather than string two pieces of inadequate vein. 
If we get good vein and it is in three or four segments, we 
will put it together in preference to using two pieces of 
mediocre vein. 
Dr. Harry L. Bush, Jr. (New York, N.Y.). The 
numbers are small, but if that group holds up as well, it 
clearly becomes a major viable alternative to most of the 
other single-conduit reconstructions that have been de- 
scribed. 
Dr. Chang. Good vein is good vein. For example, say 
external diameter of the greater saphenous vein is 4 mm 
down to the knee, and, just below the calf, it turns into a 
2.5 cm vein. A lot depends on how well the vein behaves 
when you are cutting the valves. It may appear to be 
sclerotic, but that is a very subjective thing. 
Dr. Ricotta. But will you take a spliced segment that 
is 2.5 cm and use it or will you require that the segment you 
add on be 4 ram? 
Dr. Chang. Often, in the case I was just mentioning, 
the greater saphenous vein down by the ankle will be much 
bigger than the one at the calf. In most cases we may well 
take the segment at the ankle to anastomose up to the knee 
segment and go down to the proximal tibial vessels. In 
general, use of smaller veins is contingent on the need. We 
will use veins down to 2.5 ram, but we are certainly not 
happy about it. We will try to keep the vein segments 3.5 
mm in diameter when possible, but in some of these 
patients it was not possible. We had to use whether small 
vein or sclerotic vein in an effort to try to determine 
whether it would work. 
